Univadis Practice Changers

The latest ADA update to its “Living” Standards of Medical Care in Diabetes address the use of dulaglutide (Trulicity) following recent CV outcomes data.

A recent meta-analysis shows a superior risk-benefit profile for NOACs over vitamin K antagonists in patients with Afib and early-stage CKD.

Results from the UK Biobank study reveal favorable findings on the benefit of a healthy lifestyle in older adults with an elevated genetic risk for dementia.

The FDA recently approved a nasal powder formulation of glucagon that simplifies the process of administering treatment to patients who are experiencing severe hypoglycemia but are not able to treat themselves.

A recent study examines the effect of increased physical activity in middle age on all-cause mortality.

The USPSTF recommends the use of preexposure prophylaxis (PrEP) with effective antiretroviral therapy in patients at high risk for HIV acquisition. Who is at high risk?

For more information on HIV screening and many other topics in medicine, please visit Univadis.com.

Yael Waknine talks with Dr. Neil Skolnik about the ADA's update of its treatment guidelines for patients with diabetic kidney disease based on the results of the Credence trial.

For more information on diabetes and many other topics in medicine, please visit Univadis.com.

A new study finds that the American Heart Association’s Life’s Simple 7 strategies confer a significant benefit in reducing heart failure risk.

Yael Waknine of Univadis and Dr. Neil Skolnik, Professor of Family and Community Medicine at Sidney Kimmel Medical College, discuss findings that major bleeds in stroke/TIA rare but higher with clopidogrel + aspirin.

Yael Waknine and Dr. Neil Skolnik discuss the implications of the CDC confirming the main driver of the 2019 measles outbreak.